Our Company Investor Relations

HOME > Investor Relations > IR Library > Financial Results > Financial Results 2003

Financial Results

Financial Results for the Fiscal 2003 (April 1, 2003-March 31, 2004)

Financial Statements
PDF file Financial Statements (entire file)
PDF file Consolidated Financial Results for Fiscal 2003 and Forecasts for Fiscal 2004
PDF file Group Organization
PDF file Management Policies
PDF file Operating Results and Financial Position
PDF file Consolidated Financial Statements
PDF file Summary of Significant Accounting Policies Used in Preparation of Consolidated Financial Statements
PDF file Segment Information
PDF file Marketable Securities
PDF file Production, Orders and Sales
PDF file Non-Consolidated Financial Statements for the Fiscal Year Ended March 31, 2004
PDF file Non-Consolidated Balance Sheets
PDF file Non-Consolidated Statements of Income
PDF file Non-Consolidated Statements of Retained Earnings
PDF file Summary of Significant Accounting Policies Used in Preparation of Non-Consolidated Financial Statements"Notes"Transfer of Officers
Reference Data
PDF file Reference Data (entire file)
PDF file Consolidated Financial Data
PDF file Consolidated P/L Statement
PDF file Consolidated Sales by Breakdown and Operating Income by Category
PDF file Sales of Leading Products OTC and PD
PDF file Capital Expenditure (Breakdown by Area)
PDF file Subsidiaries and Affiliates
PDF file Non-consolidated Financial Data
PDF file Non-consolidated P/L Statement
PDF file Non-consolidated Sales Breakdown by Category
PDF file Sales of Leading Products OTC"Quasi-durg and LipoD Sales Breakdown by Channel
PDF file Non-consolidated Sales Breakdown by Therapeutic Category"Capital Expenditure" Top 10 Shareholders
PDF file New Drug Pipeline
PDF file Launch of New Products (OTC)
PDF file Brief Report of Consolidated Fiscal Results
PDF file Consolidated Balance Sheets
PDF file Consolidated Statements of Income
PDF file Consolidated Statements of Retained Earnings
PDF file Consolidated Statements of Cash Flows

Financial Results for the Third Quarter of Fiscal 2003 (April 1,-December 31, 2003)

PDF file Financial Statements (entire file)

Financial Results for the First Half of Fiscal 2003 (April 1,-September 30, 2003)

Financial Statements
PDF file Financial Statements (entire file)
PDF file Consolidated Financial Results for First Half of Fiscal 2003 and Forecasts for Fiscal 2003
PDF file Group Organization
PDF file Management Policies
PDF file Operating Results and Financial Position
PDF file Interim Consolidated Financial Statements
PDF file Summary of Significant Accounting Policies Used in Preparation of Interim Consolidated Financial Statements
PDF file Segment Information
PDF file Marketable Securities
PDF file Production, Orders, and Sales
PDF file Non-Consolidated Financial Results for First Half of Fiscal 2003 and Forecasts for Fiscal 2003
PDF file Non-Consolidated Financial Statements
PDF file Summary of Significant Accounting Policies Used in Preparation of Non-Consolidated Financial Statements
Reference Data
PDF file Reference Data (entire file)
PDF file Consolidated Financial Data
PDF file Consolidated P/L Statement
PDF file Consolidated Sales by Category and Operating Income by Category
PDF file Sales of Leading Products OTC and PD
PDF file Capital Expenditure Breakdown by Area
PDF file Subsidiaries and Affiliates
PDF file Non-consolidated Financial Data
PDF file Non-consolidated P/L Statement
PDF file Non-consolidated Sales Breakdown by Category
PDF file Sales of Leading Products OTC, Quasi-drug Drinks and Lipo Sales Breakdown by Channel
PDF file Non-consolidated Sales Breakdown by Therapeutic Category"Capital Expenditure" Top 10 Shareholders
PDF file New Drug Pipeline(domestic)
PDF file New Drug Pipeline(overseas)
PDF file Launch of New Products (OTC)

Financial Results for the First Quarter of Fiscal 2003 (April 1,-June 30, 2003)

PDF file Financial Statements (entire file)
Get Adobe Reader Adobe Reader is required to view this file. Adobe Reader is distributed free of charge by Adobe Systems Incorporated.

Page Top